# A Study for Identification of Predictive Immune Biomarker for Atezolizumab Therapy in NSCLC Patients

> **NCT04312308** · — · COMPLETED · sponsor: **Yonsei University** · enrollment: 100 (actual)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **OTHER:** Sample collection

## Key facts

- **NCT ID:** NCT04312308
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-08
- **Primary completion:** 2025-01-26
- **Final completion:** 2025-01-26
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2026-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04312308

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04312308, "A Study for Identification of Predictive Immune Biomarker for Atezolizumab Therapy in NSCLC Patients". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04312308. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*